Skip to main content
Erschienen in: Virchows Archiv 5/2007

01.11.2007 | Original Article

Supplemental utility of nested PCR for the pathological diagnosis of disseminated trichosporonosis

verfasst von: Makoto Sano, Masahiko Sugitani, Toshiyuki Ishige, Taku Homma, Kentaro Kikuchi, Keishin Sunagawa, Yukari Obana, Yuki Uehara, Kazunari Kumasaka, Kumi Uenogawa, Sumiko Kobayashi, Yoshihiro Hatta, Jin Takeuchi, Norimichi Nemoto

Erschienen in: Virchows Archiv | Ausgabe 5/2007

Einloggen, um Zugang zu erhalten

Abstract

Disseminated trichosporonosis is known to be a severe opportunistic mycosis and has a high mortality rate. In autopsy cases, it is often difficult to diagnose as trichosporonosis because the causative Trichosporon species are pathologically similar to other fungi, especially the Candida species. Immunohistochemical analysis is essential for the differential diagnosis, but an antibody to Trichosporon is not available commercially. In the present study, we investigated the supplemental utility of nested polymerase chain reaction (PCR) for the pathological diagnosis of trichosporonosis from formalin-fixed and paraffin-embedded tissues. Total DNA was purified from 30 major organs in three autopsy cases, and Trichosporon DNA was specifically amplified by nested PCR using three sets of primers. Of 22 organs in which Grocott’s stain was positive for fungal infection, 170- and 259-bp PCR products were detected in 20 (91%) and 12 (55%) organs, respectively. In short-term fixation (about 1 day), these bands were highly detected in ten (100%) and nine (90%) organs, whereas the detection efficiency tended to decrease after long-term fixation and decalcification. No PCR product of 412 bp was detected in any organs. These findings suggest that nested PCR from short-term-fixed tissues is useful for supportive pathological diagnosis of disseminated trichosporonosis.
Literatur
1.
Zurück zum Zitat Abdala E, Lopes RI, Chaves CN, Heins-Vaccari EM, Shikanai-Yasuda MA (2005) Trichosporon asahii fatal infection in a non-neutropenic patient after orthotopic liver transplantation. Transpl Infect Dis 7:162–165PubMedCrossRef Abdala E, Lopes RI, Chaves CN, Heins-Vaccari EM, Shikanai-Yasuda MA (2005) Trichosporon asahii fatal infection in a non-neutropenic patient after orthotopic liver transplantation. Transpl Infect Dis 7:162–165PubMedCrossRef
2.
Zurück zum Zitat Ahmad S, Al-Mahmeed M, Khan ZU (2005) Characterization of Trichosporon species isolated from clinical specimens in Kuwait. J Med Microbiol 54:639–646PubMedCrossRef Ahmad S, Al-Mahmeed M, Khan ZU (2005) Characterization of Trichosporon species isolated from clinical specimens in Kuwait. J Med Microbiol 54:639–646PubMedCrossRef
3.
Zurück zum Zitat Antachopoulos C, Papakonstantinou E, Dotis J, Bibashi E, Tamiolaki M, Koliouskas D, Roilides E (2005) Fungemia due to Trichosporon asahii in a neutropenic child refractory to amphotericin B: clearance with voriconazole. J Pediatr Hematol Oncol 27:283–285PubMedCrossRef Antachopoulos C, Papakonstantinou E, Dotis J, Bibashi E, Tamiolaki M, Koliouskas D, Roilides E (2005) Fungemia due to Trichosporon asahii in a neutropenic child refractory to amphotericin B: clearance with voriconazole. J Pediatr Hematol Oncol 27:283–285PubMedCrossRef
4.
Zurück zum Zitat Asada N, Uryu H, Koseki M, Takeuchi M, Komatsu M, Matsue K (2006) Successful treatment of breakthrough Trichosporon asahii fungemia with voriconazole in a patient with acute myeloid leukemia. Clin Infect Dis 43:e39–e41PubMedCrossRef Asada N, Uryu H, Koseki M, Takeuchi M, Komatsu M, Matsue K (2006) Successful treatment of breakthrough Trichosporon asahii fungemia with voriconazole in a patient with acute myeloid leukemia. Clin Infect Dis 43:e39–e41PubMedCrossRef
5.
Zurück zum Zitat Erer B, Galimberti M, Lucarelli G, Giardini C, Polchi P, Baronciani D, Gaziev D, Angelucci E, Izzi G (2000) Trichosporon beigelii: a life-threatening pathogen in immunocompromised hosts. Bone Marrow Transplant 25:745–749PubMedCrossRef Erer B, Galimberti M, Lucarelli G, Giardini C, Polchi P, Baronciani D, Gaziev D, Angelucci E, Izzi G (2000) Trichosporon beigelii: a life-threatening pathogen in immunocompromised hosts. Bone Marrow Transplant 25:745–749PubMedCrossRef
6.
Zurück zum Zitat Falk R, Wolf DG, Shapiro M, Polacheck I (2003) Multidrug-resistant Trichosporon asahii isolates are susceptible to voriconazole. J Clin Microbiol 41:911PubMedCrossRef Falk R, Wolf DG, Shapiro M, Polacheck I (2003) Multidrug-resistant Trichosporon asahii isolates are susceptible to voriconazole. J Clin Microbiol 41:911PubMedCrossRef
7.
Zurück zum Zitat Fukuzawa M, Inaba H, Hayama M, Sakaguchi N, Sano K, Ito M, Hotchi M (1995) Improved detection of medically important fungi by immunoperoxidase staining with polyclonal antibodies. Virchows Arch 427:407–414PubMedCrossRef Fukuzawa M, Inaba H, Hayama M, Sakaguchi N, Sano K, Ito M, Hotchi M (1995) Improved detection of medically important fungi by immunoperoxidase staining with polyclonal antibodies. Virchows Arch 427:407–414PubMedCrossRef
8.
Zurück zum Zitat Girmenia C, Pagano L, Martino B, D’Antonio D, Fanci R, Specchia G, Melillo L, Buelli M, Pizzarelli G, Venditti M, Martino P (2005) Invasive infections caused by Trichosporon species and Geotrichum capitatum in patients with hematological malignancies: a retrospective multicenter study from Italy and review of the literature. J Clin Microbiol 43:1818–1828PubMedCrossRef Girmenia C, Pagano L, Martino B, D’Antonio D, Fanci R, Specchia G, Melillo L, Buelli M, Pizzarelli G, Venditti M, Martino P (2005) Invasive infections caused by Trichosporon species and Geotrichum capitatum in patients with hematological malignancies: a retrospective multicenter study from Italy and review of the literature. J Clin Microbiol 43:1818–1828PubMedCrossRef
9.
Zurück zum Zitat Haupt HM, Merz WG, Beschorner WE, Vaughan WP, Saral R (1983) Colonization and infection with Trichosporon species in the immunosuppressed host. J Infect Dis 147:199–203PubMed Haupt HM, Merz WG, Beschorner WE, Vaughan WP, Saral R (1983) Colonization and infection with Trichosporon species in the immunosuppressed host. J Infect Dis 147:199–203PubMed
10.
Zurück zum Zitat Jensen HE, Schonheyder HC, Hotchi M, Kaufman L (1996) Diagnosis of systemic mycoses by specific immunohistochemical tests. Apmis 104:241–258PubMedCrossRef Jensen HE, Schonheyder HC, Hotchi M, Kaufman L (1996) Diagnosis of systemic mycoses by specific immunohistochemical tests. Apmis 104:241–258PubMedCrossRef
11.
Zurück zum Zitat Kimura M, Takahashi H, Satou T, Hashimoto S (1989) An autopsy case of disseminated trichosporonosis with candidiasis of the urinary bladder. Virchows Arch A Pathol Anat Histopathol 416:159–162PubMedCrossRef Kimura M, Takahashi H, Satou T, Hashimoto S (1989) An autopsy case of disseminated trichosporonosis with candidiasis of the urinary bladder. Virchows Arch A Pathol Anat Histopathol 416:159–162PubMedCrossRef
12.
Zurück zum Zitat Kontoyiannis DP, Torres HA, Chagua M, Hachem R, Tarrand JJ, Bodey GP, Raad II (2004) Trichosporonosis in a tertiary care cancer center: risk factors, changing spectrum and determinants of outcome. Scand J Infect Dis 36:564–569PubMedCrossRef Kontoyiannis DP, Torres HA, Chagua M, Hachem R, Tarrand JJ, Bodey GP, Raad II (2004) Trichosporonosis in a tertiary care cancer center: risk factors, changing spectrum and determinants of outcome. Scand J Infect Dis 36:564–569PubMedCrossRef
13.
Zurück zum Zitat Koyanagi T, Nishida N, Osabe S, Imamura Y, Yamamoto S, Shichiji A, Nakamura Y (2006) Autopsy case of disseminated Trichosporon inkin infection identified with molecular biological and biochemical methods. Pathol Int 56:738–743PubMedCrossRef Koyanagi T, Nishida N, Osabe S, Imamura Y, Yamamoto S, Shichiji A, Nakamura Y (2006) Autopsy case of disseminated Trichosporon inkin infection identified with molecular biological and biochemical methods. Pathol Int 56:738–743PubMedCrossRef
14.
Zurück zum Zitat Krcmery V Jr, Mateicka F, Kunova A, Spanik S, Gyarfas J, Sycova Z, Trupl J (1999) Hematogenous trichosporonosis in cancer patients: report of 12 cases including 5 during prophylaxis with itraconazol. Support Care Cancer 7:39–43PubMedCrossRef Krcmery V Jr, Mateicka F, Kunova A, Spanik S, Gyarfas J, Sycova Z, Trupl J (1999) Hematogenous trichosporonosis in cancer patients: report of 12 cases including 5 during prophylaxis with itraconazol. Support Care Cancer 7:39–43PubMedCrossRef
15.
Zurück zum Zitat Krcmery V Jr, Oravcova E, Spanik S, Mrazova-Studena M, Trupl J, Kunova A, Stopkova-Grey K, Kukuckova E, Krupova I, Demitrovicova A, Kralovicova K (1998) Nosocomial breakthrough fungaemia during antifungal prophylaxis or empirical antifungal therapy in 41 cancer patients receiving antineoplastic chemotherapy: analysis of aetiology risk factors and outcome. J Antimicrob Chemother 41:373–380PubMedCrossRef Krcmery V Jr, Oravcova E, Spanik S, Mrazova-Studena M, Trupl J, Kunova A, Stopkova-Grey K, Kukuckova E, Krupova I, Demitrovicova A, Kralovicova K (1998) Nosocomial breakthrough fungaemia during antifungal prophylaxis or empirical antifungal therapy in 41 cancer patients receiving antineoplastic chemotherapy: analysis of aetiology risk factors and outcome. J Antimicrob Chemother 41:373–380PubMedCrossRef
16.
Zurück zum Zitat Marty FM, Barouch DH, Coakley EP, Baden LR (2003) Disseminated trichosporonosis caused by Trichosporon loubieri. J Clin Microbiol 41:5317–5320PubMedCrossRef Marty FM, Barouch DH, Coakley EP, Baden LR (2003) Disseminated trichosporonosis caused by Trichosporon loubieri. J Clin Microbiol 41:5317–5320PubMedCrossRef
17.
Zurück zum Zitat Matsue K, Uryu H, Koseki M, Asada N, Takeuchi M (2006) Breakthrough trichosporonosis in patients with hematologic malignancies receiving micafungin. Clin Infect Dis 42:753–757PubMedCrossRef Matsue K, Uryu H, Koseki M, Asada N, Takeuchi M (2006) Breakthrough trichosporonosis in patients with hematologic malignancies receiving micafungin. Clin Infect Dis 42:753–757PubMedCrossRef
18.
Zurück zum Zitat Middelhoven WJ (2003) Identification of clinically relevant Trichosporon species. Mycoses 46:7–11PubMedCrossRef Middelhoven WJ (2003) Identification of clinically relevant Trichosporon species. Mycoses 46:7–11PubMedCrossRef
19.
Zurück zum Zitat Nagai H, Yamakami Y, Hashimoto A, Tokimatsu I, Nasu M (1999) PCR detection of DNA specific for Trichosporon species in serum of patients with disseminated trichosporonosis. J Clin Microbiol 37:694–699PubMed Nagai H, Yamakami Y, Hashimoto A, Tokimatsu I, Nasu M (1999) PCR detection of DNA specific for Trichosporon species in serum of patients with disseminated trichosporonosis. J Clin Microbiol 37:694–699PubMed
20.
Zurück zum Zitat Nasu K, Akizuki S, Yoshiyama K, Kikuchi H, Higuchi Y, Yamamoto S (1994) Disseminated Trichosporon infection. A case report and immunohistochemical study. Arch Pathol Lab Med 118:191–194PubMed Nasu K, Akizuki S, Yoshiyama K, Kikuchi H, Higuchi Y, Yamamoto S (1994) Disseminated Trichosporon infection. A case report and immunohistochemical study. Arch Pathol Lab Med 118:191–194PubMed
21.
Zurück zum Zitat Nishiura Y, Nakagawa-Yoshida K, Suga M, Shinoda T, Gueho E, Ando M (1997) Assignment and serotyping of Trichosporon species: the causative agents of summer-type hypersensitivity pneumonitis. J Med Vet Mycol 35:45–52PubMedCrossRef Nishiura Y, Nakagawa-Yoshida K, Suga M, Shinoda T, Gueho E, Ando M (1997) Assignment and serotyping of Trichosporon species: the causative agents of summer-type hypersensitivity pneumonitis. J Med Vet Mycol 35:45–52PubMedCrossRef
22.
Zurück zum Zitat Paphitou NI, Ostrosky-Zeichner L, Paetznick VL, Rodriguez JR, Chen E, Rex JH (2002) In vitro antifungal susceptibilities of Trichosporon species. Antimicrob Agents Chemother 46:1144–1146PubMedCrossRef Paphitou NI, Ostrosky-Zeichner L, Paetznick VL, Rodriguez JR, Chen E, Rex JH (2002) In vitro antifungal susceptibilities of Trichosporon species. Antimicrob Agents Chemother 46:1144–1146PubMedCrossRef
23.
Zurück zum Zitat Pfaller MA, Diekema DJ (2004) Rare and emerging opportunistic fungal pathogens: concern for resistance beyond Candida albicans and Aspergillus fumigatus. J Clin Microbiol 42:4419–4431PubMedCrossRef Pfaller MA, Diekema DJ (2004) Rare and emerging opportunistic fungal pathogens: concern for resistance beyond Candida albicans and Aspergillus fumigatus. J Clin Microbiol 42:4419–4431PubMedCrossRef
24.
Zurück zum Zitat Pini G, Faggi E, Donato R, Fanci R (2005) Isolation of Trichosporon in a hematology ward. Mycoses 48:45–49PubMedCrossRef Pini G, Faggi E, Donato R, Fanci R (2005) Isolation of Trichosporon in a hematology ward. Mycoses 48:45–49PubMedCrossRef
25.
Zurück zum Zitat Plank J, Rychlo A (1952) A method for quick decalcification. Zentralbl Allg Pathol 89:252–254PubMed Plank J, Rychlo A (1952) A method for quick decalcification. Zentralbl Allg Pathol 89:252–254PubMed
26.
Zurück zum Zitat Sugita T, Ikeda R, Nishikawa A (2004) Analysis of Trichosporon isolates obtained from the houses of patients with summer-type hypersensitivity pneumonitis. J Clin Microbiol 42:5467–5471PubMedCrossRef Sugita T, Ikeda R, Nishikawa A (2004) Analysis of Trichosporon isolates obtained from the houses of patients with summer-type hypersensitivity pneumonitis. J Clin Microbiol 42:5467–5471PubMedCrossRef
27.
Zurück zum Zitat Sugita T, Nakajima M, Ikeda R, Niki Y, Matsushima T, Shinoda T (2001) A nested PCR assay to detect DNA in sera for the diagnosis of deep-seated trichosporonosis. Microbiol Immunol 45:143–148PubMed Sugita T, Nakajima M, Ikeda R, Niki Y, Matsushima T, Shinoda T (2001) A nested PCR assay to detect DNA in sera for the diagnosis of deep-seated trichosporonosis. Microbiol Immunol 45:143–148PubMed
28.
Zurück zum Zitat Sugita T, Nishikawa A, Ikeda R, Shinoda T, Sakashita H, Sakai Y, Yoshizawa Y (1998) First report of Trichosporon ovoides isolated from the home of a summer-type hypersensitivity pneumonitis patient. Microbiol Immunol 42:475–478PubMed Sugita T, Nishikawa A, Ikeda R, Shinoda T, Sakashita H, Sakai Y, Yoshizawa Y (1998) First report of Trichosporon ovoides isolated from the home of a summer-type hypersensitivity pneumonitis patient. Microbiol Immunol 42:475–478PubMed
29.
Zurück zum Zitat Sugita T, Nishikawa A, Shinoda T (1998) Rapid detection of species of the opportunistic yeast Trichosporon by PCR. J Clin Microbiol 36:1458–1460PubMed Sugita T, Nishikawa A, Shinoda T (1998) Rapid detection of species of the opportunistic yeast Trichosporon by PCR. J Clin Microbiol 36:1458–1460PubMed
30.
Zurück zum Zitat Tashiro T, Nagai H, Nagaoka H, Goto Y, Kamberi P, Nasu M (1995) Trichosporon beigelii pneumonia in patients with hematologic malignancies. Chest 108:190–195PubMed Tashiro T, Nagai H, Nagaoka H, Goto Y, Kamberi P, Nasu M (1995) Trichosporon beigelii pneumonia in patients with hematologic malignancies. Chest 108:190–195PubMed
31.
Zurück zum Zitat Tawara S, Ikeda F, Maki K, Morishita Y, Otomo K, Teratani N, Goto T, Tomishima M, Ohki H, Yamada A, Kawabata K, Takasugi H, Sakane K, Tanaka H, Matsumoto F, Kuwahara S (2000) In vitro activities of a new lipopeptide antifungal agent, FK463, against a variety of clinically important fungi. Antimicrob Agents Chemother 44:57–62PubMedCrossRef Tawara S, Ikeda F, Maki K, Morishita Y, Otomo K, Teratani N, Goto T, Tomishima M, Ohki H, Yamada A, Kawabata K, Takasugi H, Sakane K, Tanaka H, Matsumoto F, Kuwahara S (2000) In vitro activities of a new lipopeptide antifungal agent, FK463, against a variety of clinically important fungi. Antimicrob Agents Chemother 44:57–62PubMedCrossRef
Metadaten
Titel
Supplemental utility of nested PCR for the pathological diagnosis of disseminated trichosporonosis
verfasst von
Makoto Sano
Masahiko Sugitani
Toshiyuki Ishige
Taku Homma
Kentaro Kikuchi
Keishin Sunagawa
Yukari Obana
Yuki Uehara
Kazunari Kumasaka
Kumi Uenogawa
Sumiko Kobayashi
Yoshihiro Hatta
Jin Takeuchi
Norimichi Nemoto
Publikationsdatum
01.11.2007
Verlag
Springer-Verlag
Erschienen in
Virchows Archiv / Ausgabe 5/2007
Print ISSN: 0945-6317
Elektronische ISSN: 1432-2307
DOI
https://doi.org/10.1007/s00428-007-0484-6

Weitere Artikel der Ausgabe 5/2007

Virchows Archiv 5/2007 Zur Ausgabe

Neu im Fachgebiet Pathologie

Molekularpathologische Untersuchungen im Wandel der Zeit

Open Access Biomarker Leitthema

Um auch an kleinen Gewebeproben zuverlässige und reproduzierbare Ergebnisse zu gewährleisten ist eine strenge Qualitätskontrolle in jedem Schritt des Arbeitsablaufs erforderlich. Eine nicht ordnungsgemäße Prüfung oder Behandlung des …

Vergleichende Pathologie in der onkologischen Forschung

Pathologie Leitthema

Die vergleichende experimentelle Pathologie („comparative experimental pathology“) ist ein Fachbereich an der Schnittstelle von Human- und Veterinärmedizin. Sie widmet sich der vergleichenden Erforschung von Gemeinsamkeiten und Unterschieden von …

Gastrointestinale Stromatumoren

Open Access GIST CME-Artikel

Gastrointestinale Stromatumoren (GIST) stellen seit über 20 Jahren ein Paradigma für die zielgerichtete Therapie mit Tyrosinkinaseinhibitoren dar. Eine elementare Voraussetzung für eine mögliche neoadjuvante oder adjuvante Behandlung bei …

Personalisierte Medizin in der Onkologie

Aufgrund des erheblichen technologischen Fortschritts in der molekularen und genetischen Diagnostik sowie zunehmender Erkenntnisse über die molekulare Pathogenese von Krankheiten hat in den letzten zwei Jahrzehnten ein grundlegender …